86 related articles for article (PubMed ID: 22017843)
1. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-pressure Glaucoma Treatment Study.
Garudadri CS; Choudhari NS; Rao HL; Senthil S
Am J Ophthalmol; 2011 Nov; 152(5):877; author reply 877-8. PubMed ID: 22017843
[No Abstract] [Full Text] [Related]
2. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
[TBL] [Abstract][Full Text] [Related]
3. The rate of progression and ocular perfusion pressure in the Low-pressure Glaucoma Treatment Study.
Quaranta L; Floriani I
Am J Ophthalmol; 2011 Nov; 152(5):880; author reply 880-1. PubMed ID: 22017846
[No Abstract] [Full Text] [Related]
4. Clinical evidence for neuroprotection in glaucoma.
Cordeiro MF; Levin LA
Am J Ophthalmol; 2011 Nov; 152(5):715-6. PubMed ID: 22017839
[No Abstract] [Full Text] [Related]
5. Risk factors for visual field progression in the low-pressure glaucoma treatment study.
De Moraes CG; Liebmann JM; Greenfield DS; Gardiner SK; Ritch R; Krupin T;
Am J Ophthalmol; 2012 Oct; 154(4):702-11. PubMed ID: 22835512
[TBL] [Abstract][Full Text] [Related]
6. Effect of brimonidine on retinal vascular autoregulation and short-term visual function in normal tension glaucoma.
Feke GT; Bex PJ; Taylor CP; Rhee DJ; Turalba AV; Chen TC; Wand M; Pasquale LR
Am J Ophthalmol; 2014 Jul; 158(1):105-112.e1. PubMed ID: 24709811
[TBL] [Abstract][Full Text] [Related]
7. Ulcerated infantile hemangioma: novel treatment with topical brimonidine-timolol.
Beal BT; Chu MB; Siegfried EC
Pediatr Dermatol; 2014; 31(6):754-6. PubMed ID: 25424217
[TBL] [Abstract][Full Text] [Related]
8. Special considerations in low-tension glaucoma.
Krupin T
Can J Ophthalmol; 2007 Jun; 42(3):414-7. PubMed ID: 17508037
[TBL] [Abstract][Full Text] [Related]
9. Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.
Craven ER; Walters TR; Williams R; Chou C; Cheetham JK; Schiffman R;
J Ocul Pharmacol Ther; 2005 Aug; 21(4):337-48. PubMed ID: 16117698
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of randomized controlled trials comparing timolol with brimonidine in the treatment of glaucoma.
Loon SC; Liew G; Fung A; Reid SE; Craig JC
Clin Exp Ophthalmol; 2008 Apr; 36(3):281-9. PubMed ID: 18412600
[TBL] [Abstract][Full Text] [Related]
11. Pressure or progression?
Burnstein Y; Robin AL
Arch Ophthalmol; 1999 Mar; 117(3):417-9. PubMed ID: 10088833
[No Abstract] [Full Text] [Related]
12. The short-term effect of adding brimonidine 0.2% to timolol treatment in patients with open-angle glaucoma.
Yüksel N; Altintaş O; Karabaş L; Alp B; Cağlar Y
Ophthalmologica; 1999; 213(4):228-33. PubMed ID: 10420106
[TBL] [Abstract][Full Text] [Related]
13. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
14. Normal-tension glaucoma.
Anderson DR; Feuer W; Schiffman J
Ophthalmology; 2008 Mar; 115(3):590-1; author reply 591-2. PubMed ID: 18319115
[No Abstract] [Full Text] [Related]
15. A short term study of the additive effect of timolol and brimonidine on intraocular pressure.
Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A
Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886
[TBL] [Abstract][Full Text] [Related]
16. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
Razeghinejad MR; Sawchyn AK; Katz LJ
Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for progression of normal-tension glaucoma under β-blocker monotherapy.
Araie M; Shirato S; Yamazaki Y; Matsumoto C; Kitazawa Y; Ohashi Y;
Acta Ophthalmol; 2012 Aug; 90(5):e337-43. PubMed ID: 22551324
[TBL] [Abstract][Full Text] [Related]
18. Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma.
Mizoue S; Nitta K; Shirakashi M; Nitta A; Yamabayashi S; Kimura T; Ueda T; Takeda R; Matsumoto S; Yoshikawa K
Adv Ther; 2017 Jun; 34(6):1438-1448. PubMed ID: 28508306
[TBL] [Abstract][Full Text] [Related]
19. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
[TBL] [Abstract][Full Text] [Related]
20. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
Greenfield DS; Liebmann JM; Ritch R
J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]